2487 — Cutia Therapeutics Balance Sheet
0.000.00%
- HK$1.95bn
- HK$847.91m
- CNY137.62m
Annual balance sheet for Cutia Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 1,378 | 1,077 | 1,273 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.499 | 4.12 | 77 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 1,402 | 1,145 | 1,416 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 62.9 | 240 | 231 |
Net Intangible Assets | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 1,495 | 1,447 | 1,707 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 19.3 | 77.4 | 255 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 2,285 | 2,693 | 358 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | -791 | -1,246 | 1,349 |
Total Liabilities & Shareholders' Equity | 1,495 | 1,447 | 1,707 |
Total Common Shares Outstanding |